The global diabetes crisis is worsening. With over 537 million people currently living with diabetes worldwide, the ...

CAMPERDOWN cyclist Bailey McDonald will move to Europe for a dream job after signing his first professional contract.

We're days away from what could be a historic election, in a highly unusual campaign season. America could get its first ...

Healthcare is possibly the most overlooked of all the mega-trends. But this may leave investors with more opportunities once ...

Danish pharmaceutical company Novo Nordisk (NYSE: NVO) is pioneering a new wave of medical treatment for diabetes and obesity care. The company develops a long line of blockbuster glucagon-like ...

This marks Novo Nordisk's second win this year in treating cardiovascular disease. The company develops a long line of blockbuster glucagon-like peptide-1 (GLP-1) agonists, including Ozempic ...

And Novo Nordisk is asking the U.S. Food and Drug Administration (FDA) to bar compounding pharmacies from making off-brand versions of semaglutide, the active ingredient in its blockbuster weight ...

Shares in Novo Nordisk A/S (DK:NOVO.B) have lost a fifth of their market value since the end of June, the point at which the Danish pharma group revealed that it was committing around $4bn (£3.2bn) to ...

Novo Business Checking Review (2024): Is Novo a Trusted Bank? Your email has been sent You might be wondering if Novo is the right fit for your business? In the following sections we’ll be ...